Healthcare resource utilization and expenditures of women diagnosed with hypoactive sexual desire disorder.

Sexual arousal: Sex matters. Nature (2017) 0.75

Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis. Curr Med Res Opin (2015) 1.43

Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation. Am J Cardiovasc Drugs (2012) 1.41

Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol (2002) 1.23

The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes. J Nucl Cardiol (2009) 1.12

Transportation and aging: a research agenda for advancing safe mobility. Gerontologist (2007) 1.11

Healthcare utilization and costs of systemic lupus erythematosus in Medicaid. Biomed Res Int (2012) 0.93

Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States. Clin Ther (2013) 0.93

Potential health care cost savings associated with early treatment of multiple sclerosis using disease-modifying therapy. Clin Ther (2011) 0.90

Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis. J Med Econ (2015) 0.85

Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study. Clin Ther (2012) 0.85

Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study. BMC Neurol (2011) 0.85

Linkage and association analyses of type 2 diabetes/impaired glucose metabolism and adiponectin serum levels in Japanese Americans from Hawaii. Diabetes (2007) 0.83

Venous thromboembolism in the US: does race matter? J Thromb Thrombolysis (2011) 0.82

Herpes zoster-attributable resource utilization and cost burden in patients with solid organ transplant. Transplantation (2014) 0.81

Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay. Am J Health Syst Pharm (2012) 0.81

Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine. Am J Health Syst Pharm (2013) 0.80

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting. J Dermatolog Treat (2013) 0.80

Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact. Pain Med (2014) 0.75